Top Abstract Purchase Related
Home
>
Node
>
Subnode

Drug discovery in tuberculosis: a molecular approach

Mitra, P.P.

Indian Journal of Tuberculosis 59(4): 194-206

2012

ISSN/ISBN: 0019-5707
PMID: 23342539
Document Number: 659041
Despite unquestionable success of the combination drug therapy, tuberculosis (TB) very recently has drawn major attention because of the global upsurge of MDR-TB, XDR -TB and HIV-TB co-infection cases. In the last four decades, only one compound is added to the treatment regimen leaving ample opportunities to find out a new generation of TB drugs. The modern concept of drug discovery utilizes the integrated knowledge of genomics, proteomics, molecular biology and systems biology to identify more specific targets. The purpose of this review is to revisit the field of tuberculosis drug discovery based on those new concepts to identify novel targets.

Document emailed within 1 workday
Secure & encrypted payments

Kashyap, A.; Singh, P.Kumar.; Silakari, O. 2018: Counting on Fragment Based Drug Design Approach for Drug Discovery Current Topics in Medicinal Chemistry 18(27): 2284-2293
Vilar, S.; Sobarzo-Sanchez, E.; Santana, L.; Uriarte, E. 2017: Molecular Docking and Drug Discovery in β-Adrenergic Receptors Current Medicinal Chemistry 24(39): 4340-4359
Kojima, H.; Okabe, T.; Nagano, T. 2013: Open innovation center for drug discovery: a research-supporting network for drug discovery Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 141(6): 327-332
Ajaiyeoba, E.O.; Ogbole, O.O. 2006: A phytotherapeutic approach to Nigerian anti-HIV and immunomodulatory drug discovery African Journal of Medicine and Medical Sciences 35 Suppl: 71-76
Fujita, Y. 2013: Innovation by TaNeDS (Take a New challenge of Drug diScovery) collaborative drug discovery project Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(2): 89-95
Shen, Y. 2007: Discovery on Target 2007--CHI's Fifth Annual Conference. RNAi for Drug Discovery and Therapeutics IDrugs: the investigational drugs journal 10(12): 848-850
Young, S.S. 1999: Discovery 99: accelerate and improve the drug discovery process. 26-29 April 1999, San Diego, CA, USA IDrugs: the investigational drugs journal 2(7): 648-649
Sulistijawati, R.Sri.; Icksan, A.Ghanie.; Lolong, D.Bisara.; Nurwidya, F. 2019: Thoracic Radiography Characteristics of Drug Sensitive Tuberculosis and Multi Drug Resistant Tuberculosis: A Study of Indonesian National Tuberculosis Prevalence Survey Acta Medica 62(1): 24-29
Varela, G.; Carvajales, S.; Gadea, P.; Sirok, A.; Grotiuz, G.; Mota, M.I.; Ritacco, V.; Reniero, A.; Rivas, C.; Schelotto, F. 2005: Comparative molecular study of Mycobacterium tuberculosis strains, in times of antimicrobial drug resistance Revista Argentina de Microbiologia 37(1): 11-15
Alhenc-Gelas, Fçois.; Parmentier, L.; Bisagni, A. 2003: Pharmacogenetic and pharmacogenomic studies. Impact on drug discovery and drug development Therapie 58(3): 275-282
Emilien, G.; Maloteaux, J.M. 1998: Pharmacological management of epilepsy. Mechanism of action, pharmacokinetic drug interactions, and new drug discovery possibilities International Journal of Clinical Pharmacology and Therapeutics 36(4): 181-194
Armetti, L. 1999: Round table: The Italian Pharmacology Society and the drug industry: new processes in drug discovery and the contribution of universities Bollettino chimico farmaceutico 138(11): 596-598
Bittner, B.; Mountfield, R.J. 2002: Intravenous administration of poorly soluble new drug entities in early drug discovery: the potential impact of formulation on pharmacokinetic parameters Current Opinion in Drug Discovery and Development 5(1): 59-71
Katalinić-Janković, V.; Obrovac, M. 2004: Drug-resistant tuberculosis: resistance mechanisms and drug susceptibility of Mycobacterium tuberculosis Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 58(4): 323-328
Gabuda, S.P.; Rzhavin, A.F. 1976: Discovery of age effect in molecular structure of collagen Molekuliarnaia Biologiia 10(5): 998-1001
Chuchottaworn, C.; Saipan, B.; Kittisup, C.; Cheewakul, K. 2012: Adverse drug reactions and outcome of short course anti-tuberculosis drugs between single daily dose and split drug dose (BID) in pulmonary tuberculosis Journal of the Medical Association of Thailand 95(Suppl 8): S1-S5
Therese, K.L.; Gayathri, R.; Dhanurekha, L.; Sridhar, R.; Meenakshi, N.; Madhavan, H.N.; Manoj, S.E.; Vinayagam, A.K. 2012: Detection of Mycobacterium tuberculosis directly from sputum specimens and phenotypic drug resistance pattern of M. tuberculosis isolates from suspected tuberculosis patients in Chennai Indian Journal of Medical Research 135(5): 778-782
Williams, M. 2003: Genome-based drug discovery: prioritizing disease-susceptibility/disease-associated genes as novel drug targets for schizophrenia Current Opinion in Investigational Drugs 4(1): 31-36
Yoshida, M. 1999: Discovery of cell cycle inhibitors and their application to molecular biology Japanese Journal of Antibiotics 52(2): 172-173
Carr, D.T.; Karlson, A.G.; Miller, W.E. 1971: Clues to discovery of pulmonary tuberculosis Minnesota Medicine 54(5): 319-320